IRCT1138901221180N13CompletedPhase 2
Comparison of Intravitreal Bevacizumab and Triamcinolone with Placebo in Acute Nonarteritic Anterior Ischemic Optic Neuropathy
Ophthalmic Research Center0 sites16 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 16
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- no limit to no limit (—)
- Sex
- All
Inclusion Criteria
- •sudden mono ocular vision loss associated with optic disc edema and positive Marcus Gunn (<30 days). Exclusion criteria: any eye disease except NAION (Nonarteritic Anterior Ischemic Optic Neuropathy), neurologic defect, abnormal ESR, CRP, any history of retina or vitrea surgery, severe corneal opacity which makes retina examination impossible.
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Not Applicable
Comparison of Intravitreal Anti-VEGF Versus Combination Therapy in Central Retinal Vein OcclusionCentral Retinal Vein Occlusion With Macular EdemaNCT04812977Hayatabad Medical Complex30
Completed
Not Applicable
Intra ocular injection of Bevacizumab and Triamcinolone for diabetic visual loss.CTRI/2014/09/005070ethradhama Superspeciality Eye Hospita15
Completed
Phase 3
Comparative Efficacy of Intravitreal Bevacizumab and Topical Diclofenac Combined Therapy, Intravitreal Ketorolac, and Intravitreal Bevacizumab on Diabetic Macular Edemadiabetic macular edemaEye - Diseases / disorders of the eyeMetabolic and Endocrine - Diabetesdiabetes mellitusACTRN12622000313730Supanji Haryanto82
Unknown
Phase 3
Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical TrialDiabetic Macular EdemaNCT00370422Shahid Beheshti University of Medical Sciences
Completed
Not Applicable
Intravitreal ranibizumab versus bevacizumab for treatment of myopic choroidal neovascularizatioJPRN-UMIN000008588Department of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele50